Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitro-Reference-Cited by-同舟云学术

Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitro

Published:2017-05-30 Issue:5 Volume:40 Page:1566-1575
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Dharmapatni Anak A. S. S. K.,Algate Kent,Coleman Roxanne,Lorimer Michelle,Cantley Melissa D.,Smith Malcolm D.,Wechalekar Mihir D.,Crotti Tania N.

Funder

Arthritis Foundation of Australia

American Society for Bone and Mineral Research

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s10753-017-0597-2/fulltext.html

Reference47 articles.

1. Aletaha, D., T. Neogi, A. Silman, J. Funovits, D. Felson, C. Bingham, et al. 2010. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism 62: 2569–2581.

2. van de Sande, M., M. de Hair, C. van der Leij, P. Klarenbeek, W. Bos, M. Smith, et al. 2011. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Annals of the Rheumatic Diseases 70: 772–777.

3. Ashton, B.A., I.K. Ashton, M.J. Marshall, and R.C. Butler. 1993. Localisation of vitronectin receptor immunoreactivity and tartrate resistant acid phosphatase activity in synovium from patients with inflammatory or degenerative arthritis. Annals of the Rheumatic Diseases 52: 133–137.

4. Chang, J.S., J.M. Quinn, A. Demaziere, C.J. Bulstrode, M.J. Francis, R.B. Duthie, et al. 1992. Bone resorption by cells isolated from rheumatoid synovium. Annals of the Rheumatic Diseases 51: 1223–1229.

5. Haynes, D., T. Crotti, M. Loric, G. Bain, G. Atkins, and D. Findlay. 2001. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford, England) 40: 623–630.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the associations between elevated plasma SP-D levels and OSCAR gene expression as potential biomarkers in patients with COPD: a cross-sectional study;Frontiers in Pharmacology;2024-07-18

2. The predictive value of soluble osteoclast-associated receptor for the prognosis of acute coronary syndrome;Scientific Reports;2021-06-01

3. Tumour necrosis factor‐α promotes BMHSC differentiation by increasing P2X7 receptor in oestrogen‐deficient osteoporosis;Journal of Cellular and Molecular Medicine;2020-11-09

4. The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast;BioMed Research International;2020-02-21

5. Local Administration of Stem Cells from Human Exfoliated Primary Teeth Attenuate Experimental Periodontitis in Mice;CHIN J DENT RES;2019